September 23, 2026 at 08:23 PM UTC
Jazz Pharmaceuticals plc reports material agreement in SEC 8-K
Jazz Pharmaceuticals plc filed an 8-K covering a material definitive agreement and a direct financial obligation. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: September 23, 2026 at 08:15 PM UTC
Open official source